Clinically relevant core genes for hematologic malignancies in clinical NGS panel testing

被引:1
|
作者
Song, Ju Sun [1 ,2 ]
机构
[1] GC Labs, GC Genome, Yongin, South Korea
[2] GC Labs, 107 Ihyeon Ro 30beon Gil, Yongin 16924, South Korea
关键词
HEALTH-ORGANIZATION CLASSIFICATION; SOMATIC MUTATIONS; 5TH EDITION; LYMPHOMA; RESISTANCE;
D O I
10.5045/br.2023.2023196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:224 / 228
页数:5
相关论文
共 50 条
  • [1] Clinical testing and implementation of the TruSight Myeloid Next Generation Sequencing (NGS) panel for identification of clinically relevant variants in hematological malignancies
    Thomas, Mariam
    Sukhai, Mahadeo
    Zhang, Tong
    Harbi, Djamel
    De Souza, Justin
    MacDonald, Katherine
    Pugh, Trevor
    Minden, Mark
    Schuh, Andre
    Stockley, Tracy L.
    Kamel-Reid, Suzanne
    CANCER RESEARCH, 2015, 75
  • [2] Custom 68-Gene NGS Panel for Molecular Testing of Solid Tumors and Hematologic Malignancies
    Xu, D.
    Yi, H.
    Christensen, T.
    Berry, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 782 - 782
  • [3] The UHN NGS Panel for Hematologic Malignancies: Use for Standard of Care Testing of Acute Myeloid Leukemia in Ontario/Canada
    Capo-Chichi, J. M.
    Grenier, S.
    Badduke, C.
    Chin, K.
    Swindell, A.
    Stickle, N.
    Downs, G.
    Nwachukwu, B.
    Zhang, T.
    Kamel-Reid, S.
    Stockley, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S15 - S16
  • [4] Clinical utility of a multigene panel for hematologic malignancies
    Bozdogan, Sevcan Tug
    Rencuzogullari, Cagla
    Mujde, Cem
    Bisgin, Atil
    CANCER RESEARCH, 2020, 80 (16)
  • [5] DETECTION OF CLINICALLY RELEVANT ALTERATIONS IN CHRONIC LYMPHATIC LEUKEMIA BY AN NGS PANEL
    Ariceta Ganuza, B.
    Manu, A.
    Larrayoz, M. J.
    Vazquez, I
    Aguilera-Diaz, A.
    Palomino-Echeverria, S.
    Blasco-Iturri, Z.
    Irigoyen-Barranco, A.
    Ongay, Y.
    MarinArbizu, M.
    Prosper, F.
    Rifon, J.
    Arguinano, J. M.
    Fernandez-Mercado, M.
    Calasanz, M. J.
    HAEMATOLOGICA, 2019, 104 : 249 - 249
  • [6] Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies
    Levy, Michael A.
    Santos, Stephanie
    Kerkhof, Jennifer
    Stuart, Alan
    Aref-Eshghi, Erfan
    Guo, Fen
    Hedley, Ben
    Wong, Henry
    Rauh, Michael
    Feilotter, Harriet
    Berardi, Philip
    Semenuk, Laura
    Yang, Ping
    Kno, Joan
    Ainsworth, Peter
    McLachlin, Catherine Meg
    Chin-Yee, Ian
    Kovacs, Michael
    Deotare, Uday
    Lazo-Langner, Alejandro
    Hsia, Cyrus
    Keeney, Mike
    Xenocostas, Anargyros
    Howlett, Christopher
    Lin, Hanxin
    Sadikovic, Bekim
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (03) : 178 - 189
  • [7] Development of a Targeted NGS Panel for Hematologic Malignancies According to Who/ICC 2022 Guidelines
    Lee, Young Eun
    Kim, Hye Ran
    Lim, Ha Jin
    Choi, Yong Jun
    Park, Joo Heon
    Choi, Hyun-Woo
    Choi, Hyun-Jung
    Kee, Seung-Jung
    Kim, Soo Hyun
    Shin, Jong Hee
    Park, Chang Soo
    Shin, Myung Geun
    BLOOD, 2023, 142
  • [8] Utility of a Pan Genomic Fusion Panel (1300 Genes) on a Next Generation Sequencing (NGS) Platform in Evaluation of Hematologic Malignancies (HM)
    Kolhe, Ravindra
    Chaubey, Alka
    Watson, Lisa C.
    Lee, WonSok
    Jagdale, Deepa
    Attwooll, Claire
    Mondal, Ashis K.
    MODERN PATHOLOGY, 2016, 29 : 356A - 356A
  • [9] Utility of a Pan Genomic Fusion Panel (1300 Genes) on a Next Generation Sequencing (NGS) Platform in Evaluation of Hematologic Malignancies (HM)
    Kolhe, Ravindra
    Chaubey, Alka
    Watson, Lisa C.
    Lee, WonSok
    Jagdale, Deepa
    Attwooll, Claire
    Mondal, Ashis K.
    LABORATORY INVESTIGATION, 2016, 96 : 356A - 356A
  • [10] Incidental "Metagenomic" Findings Using a Next-generation Sequencing (NGS) Panel for Hematologic Malignancies
    Bessonen, K.
    Hubbard, M.
    Frederick, L.
    Devine, D.
    He, R.
    Viswanatha, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1028 - 1029